Document:

Exhibit 10.2

 

 

		 	 

 

 (1) BioArkive, LLC

 

-    and    -

 

(2) Immuneering
Corporation

 

 

 

MASTER SERVICES
AGREEMENT

 

 

 

    
	BioArkive & Immuneering	1/11	 

     

    

 

MASTER SERVICES AGREEMENT

 

This Master
Services Agreement (“Agreement”), effective as of August 5th, 2019 (“Effective
Date”), is made by and between Bioarkive LLC, a limited liability company under the laws of California, USA, having its
registered offices and principal place of business at 11421 W Bernardo Court (Suite 200), San Diego, CA 92127 (hereinafter referred
to as “Bioarkive”); and Immuneering Corporation, a corporation, incorporated under the laws of Delaware,
USA, having its registered offices and principal place of business at 245 Main St, Second Floor, Cambridge, MA 02142 (hereinafter
referred to as “Client”).

 

Hereinafter each party
may also individually be referred to as a “Party” and collectively as the “Parties”.

 

WHEREAS, Client is engaged in the field
of drug discovery;

 

WHEREAS, Bioarkive is engaged in business
in the field of preclinical research services and biorepository services;

 

WHEREAS, Bioarkive is willing to provide
contract research and development services, as defined below and hereby represents that this undertaking does not conflict with its duties
and obligations under any other agreement to which it is a party, including any agreement with any other company or institution, and

 

WHEREAS, Client and/or its affiliated companies
as the case may be, wish to engage Bioarkive for the purpose of literature study, molecular and cell biology research, assay development,
biostorage, data analysis, and testing therapeutic agents as further specified in a related Project Proposal or related services which
Bioarkive may offer on a project-by-project basis.

 

NOW, THEREFORE, IT IS AGREED AS FOLLOWS:

 

 

1.0       BIOARKIVE
SERVICES

 

1.1       Upon
engagement by Client hereunder, Bioarkive, (hereinafter referred as to as the “Service Provider”), shall perform preclinical
services, including (but not limited to) molecular and cellular biology assays and/or early process research services which may include
(but not limited to) literature study, molecular modeling and assay design, feasibility studies and other related services (collectively,
the “Services”) for Client. The Service Provider will prepare a quotation or project proposal (“Project Proposal”)
for each request from Client in which, as appropriate, the project goal and/or purpose, the information desired, the experimental procedures
or general synthetic approach (derived from literature, patents or other sources of information), the estimated duration of the project,
the price, payment terms and payment schedule and all other relevant matters will be described.

 

1.2       The
nature of the Services to be performed by the Service Provider with respect to any individual project as described in a Project
Proposal (“Project”) shall be mutually agreed by the Parties and set forth in a Project Proposal that will become
an attachment to this Agreement and will be signed by the Client and the relevant Service Provider. An example of the highlights of
a Project Proposal is attached to this Agreement as Appendix 1. Each accepted Project Proposal or any other written assignment
related to a Project Proposal shall be subject to all of the terms and conditions of this Agreement. To the extent any terms or
provisions of a Project Proposal conflict with the terms and provisions of this Agreement, the terms and provisions of this
Agreement shall prevail unless the Project Proposal, signed by both Parties, expressly states to the contrary. Bioarkive agrees that
during the term of this Agreement, there is neither a minimum number of Projects for which Client is obligated to utilize Bioarkive,
nor does this Agreement in any way limit Client’s right to contract with any other Party to provide services similar to that
which Bioarkive provides under this Agreement.

 

    
	BioArkive & Immuneering	2/11	 

     

    

 

1.3       In
the event that Bioarkive perform any work or Services prior to execution by the Parties of an accepted Project Proposal for such work
or Services, the terms and conditions of this Agreement shall also apply to any such work and Services performed by Bioarkive.

 

1.4       In
consideration of the Services that are performed by the Service Provider under this Agreement, Client will pay the Service Provider the
price that has been agreed upon for each accepted Project Proposal or any other written assignment related to a Project Proposal.

 

Payment and/or reimbursement shall be (a) in accordance
with the terms of the accepted Project Proposal or any other written assignment related to a Project Proposal and (b) accompanied by an
invoice from the Service Provider reasonably documenting actual costs charged and/or fees earned. All fees and reimbursable expenses relating
to the Services described in an accepted Project Proposal shall be payable and invoiced upon completion of all Services or according to
the agreed payment schedule as outlined in the accepted Project Proposal. Invoices received and thereafter approved for payment by Client
shall be paid to the Service Provider within thirty (30) days after date of invoice.

 

1.5       If requested by Client, the Service Provider shall consult with Client to assist Client in describing the Project goal and/or purpose.
Bioarkive represents that the Service Provider will provide all reasonable efforts to assist Client in a manner consistent with current
regulatory guidelines.

 

1.6       The
Service Provider shall appoint a "Project Manager" to be responsible for a Project performed for Client. The Project Manager
shall coordinate performance of the Project with a representative designated by Client, which representative shall have responsibility
over all matters related to the outcome of the Project on behalf of Client.

 

1.7       The
Service Provider will communicate with Client scientists and with Client on a regular basis, and will respond upon all reasonable requests,
regarding all Projects. The Service Provider will provide written reports to Client at regular, defined and mutually agreeable intervals
describing the results and including full experimental procedures, as further set forth in the Project Proposal.

 

1.8       The
Service Provider shall retain for a period of at least five (5) years from the completion of a Project or such mandatory period as defined
by applicable laws, whichever is longer, (a) experimental records and laboratory notebooks containing experimental descriptions and data
generated from such Project and may store (b) research samples, where applicable, for reference purposes.

 

    
	BioArkive & Immuneering	3/11	 

     

    

 

2.0       COMPLIANCE
WITH GOVERNMENT REGULATIONS

 

2.1       The
Service Provider shall perform each Project in accordance with applicable laws, regulations, the current state of the laboratory research
art and the relevant Project Proposal. The Service Provider shall also comply with all applicable current government regulatory requirements.
In the event Client requires any special procedures to be undertaken by the Service Provider (e.g., to satisfy foreign standards or requirements
or otherwise) such procedures ("Client Procedures") will be provided in writing by Client to the Service Provider and require
prior written approval by the Service Provider. Service Provider shall perform each Project in accordance with all agreed-upon Client
Procedures.

 

		2.2	The Service Provider shall provide the following for each Project:

 

		(a)	Labor, facilities and materials

 

		(b)	Preclinical data analysis experiments completed during a Project including an interim summary report;

 

		(c)	Subject to section 1.8 and upon request of Client any data and other research materials resulting from
a Project;

 

		(d)	A final report setting forth a full summary of the results of a Project, including a summary of all relevant
data; and

 

		(e)	Necessary professional and support personnel for a Project.

 

2.3       Bioarkive
shall assure compliance with all applicable laws and regulations regarding the disposal of hazardous materials.

 

3.0       CONFIDENTIAL
INFORMATION

 

3.1       During
the Term of this Agreement and for a period of seven (7) years following the termination or expiration, either Party agrees to retain
in confidence and to refrain from disclosing or using for its benefit or the benefit of any third party, any and all information, test
materials or data disclosed to such Party by the other Party ("Confidential Information"). This restriction shall not
apply to Confidential Information:

 

		(a)	in or entering the public domain (through no fault of the receiving Party);

 

		(b)	made available to the receiving Party by an independent third party owing no obligation of confidentiality
to the disclosing Party with regard thereto;

 

		(c)	already in the receiving Party's possession at the time of receipt from the disclosing Party (and such
prior possession can be properly demonstrated by the receiving Party);

 

		(d)	that are independently developed by the receiving Party without the aid, application or use of the Confidential
Information (and such independent development can be properly demonstrated by the receiving Party); or

 

		(e)	that are required by law, regulation, rule, act, or order of
any governmental authority or agency to be disclosed by the receiving Party; provided, however, that the receiving Party
(i) gives the disclosing Party sufficient advance written notice to permit it to seek a protective order or other similar order with
respect to such Confidential Information received hereunder and (ii) thereafter discloses only the minimum Confidential Information required
to be disclosed in order to comply, whether or not a protective order or other similar order is obtained by the disclosing Party.

 

    
	BioArkive & Immuneering	4/11	 

     

    

 

Either Party shall only provide the Confidential
Information received from the other Party hereunder to its directors, officers, employees, agents, subcontractors, and consultants who
are directly concerned with a Project and who have written obligations of confidentiality with such Party substantially similar to those
set forth herein.

 

3.2       Upon
completion of a Project or at any other time at the disclosing Party's request, the receiving Party shall upon request either destroy
or promptly return to the disclosing Party any and all Confidential Information, in any form or media, except that the receiving Party
shall be entitled to retain one (1) archival copy of such Confidential Information for legal purposes.

 

3.3       The
provision contained in this section 3, equally apply to any and all information, test materials or data generated under the Project and
owned by Client pursuant to section 4, which information, test materials or data shall be considered Confidential Information of the Client.

 

4.0       PROJECT
RESULTS

 

4.1       All
data and information, including Client Inventions as defined under 5.1, arising from the performance of the Services listed in the accepted
Project Proposal hereunder, (including but not limited to records, original experimental reports, other material(s) and data), except
to the extent such experimental data and information solely relate to the Bioarkive Property (as defined in section 5.2), shall be deemed
the intellectual property of Client (“Client Results”).

 

4.2       Client
shall retain title to and shall have the right to publish all Client Results. Client Results shall be retained in the Bioarkive archive
in compliance with regulatory and legal requirements or at such archival site as determined by Client at Client’s expense.

 

4.3        Any and all results generated during or resulting from the Services performed by Bioarkive that solely relate to the Bioarkive Property,
shall be deemed the intellectual property of Bioarkive.

 

4.4       Electronic archival,
if available, shall be kept in accordance with the industry standard and in compliance with relevant regulatory and legal requirement.

 

4.5       To
the extent that Services to be performed under a Project Proposal include the development of novel, non-standard preclinical assays for
use by Client (each, a "Client-Specific Assay"), each Client-Specific Assay shall be owned by Bioarkive but (a) be licensed
exclusively by Bioarkive to Client for use exclusively by or on behalf of Client for a period of three years, and (b) thereafter be licensed
non-exclusively by Bioarkive to Client thereafter for use by or on behalf of Client. Such license shall at all times be worldwide, perpectual,
irrevocable, royalty-free and fully paid-up.

 

5.0       INVENTIONS
AND PATENTS

 

5.1       Bioarkive
shall promptly notify Client in writing of any and all ideas, innovations, inventions, methods, developments or improvements, whether
or not patentable, discovered or arising from the performance of a Project conducted hereunder to the extent such experimental data and
information do not relate to the Bioarkive Property ("Client Inventions"). Subject to Section 4.5, Bioarkive hereby assigns
and agrees to assign to Client all rights, title and interest in and to such Client Inventions. If Client requests, and at Client's expense,
Bioarkive shall provide Client with reasonable assistance to obtain patents for such Client Inventions.

 

    
	BioArkive & Immuneering	5/11	 

     

    

 

5.2       The
Parties acknowledge and agree that Bioarkive has proprietary testing protocols, processes, programming, methodology, techniques, equipment
and know-how existing as of the Effective Date of this Agreement or developed wholly independent of the Services that are its sole and
exclusive property (“Bioarkive Property”) and that any ideas, innovations, inventions, developments or improvements,
whether or not patentable, solely relating to such testing protocols, processes, programming, methodology, techniques, equipment and know-how
conceived solely by Bioarkive shall be and remain the sole and exclusive intellectual property of Bioarkive, subject to Section 4.5.

 

6.0       
LIABILITY

 

6.1       The
Service Provider accepts only liability towards Client in respect of damages resulting from a failure directly attributable to the Service
Provider in the performance of its obligations under this Agreement or for gross negligence or willful misconduct. The Service Provider
shall not be liable for any damage originating from any materials or information supplied by Client hereunder provided such materials
and information are only used by Bioarkive for the performance of its obligations hereunder in its premises under suitable containment
conditions.

 

6.2       In the event of improper, incorrect performance or performance not in accordance with applicable standards or applicable laws by the Service
Provider of the work under the Services, Client shall have the right to demand the Service Provider to re-perform the work without any
charge to Client.

 

6.3       Except in instances of breaches of confidentiality, gross negligence or willful misconduct, the liability of the Service Provider for
any shortcomings in the execution of the Services will be limited to a maximum of the fees for the Services that Service Provider has
received for the Services provided hereunder.

 

6.4       EXCEPT FOR THE WARRANTIES PROVIDED IN THIS AGREEMENT, THE SERVICE PROVIDER MAKES ANY WARRANTY, EXPRESS OR IMPLIED, BY STATUTE OR IN WRITING,
REGARDING THE SERVICES OR ANY PRODUCT RESULTING FROM THE SERVICES, INCLUDING WITHOUT LIMITATION ANY WARRANTY REGARDING THEIR FITNESS FOR
ANY PURPOSE, THEIR QUALITY, THEIR MERCHANTABILITY OR THEIR NON-INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES. ANY OTHER
REPRESENTATIONS OR WARRANTIES MADE BY ANY PERSON OR ENTITY, INCLUDING EMPLOYEES OR REPRESENTATIVES OF THE SERVICE PROVIDER, THAT ARE INCONSISTENT
HEREWITH, SHALL BE DISREGARDED AND SHALL NOT BE BINDING ON THE SERVICE PROVIDER.

 

6.5       Except to the extent arising from Bioarkive's gross negligence or willful misconduct, the Client shall indemnify and hold Bioarkive and
its affiliated companies harmless from any third-party claims arising out of the use of the Client Results.

 

6.6       NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR INDIRECT, INCIDENTIAL OR CONSEQUENTIAL DAMAGES ARISING OUT ANY TERMS AND CONDITIONS
OF THIS AGREEMENT OR WITH RESPECT TO ITS PERFORMANCE HEREUNDER EXCEPT TO THE EXTENT SUCH DAMAGES WERE CAUSED BY GROSS NEGLIGENCE OR WILLFUL
MISCONDUCT OF SUCH PARTY.

 

6.7       Each
Party will secure and maintain in full force and effect throughout the term of this Agreement adequate insurance coverage appropriate
for the business of the type that is subject of this Agreement and its obligations under this Agreement. If requested by a Party, the
other Party shall provide the first Party with photocopies of the relevant certificates of insurance.

 

    
	BioArkive & Immuneering	6/11	 

     

    

 

7.0        TERM
AND TERMINATION

 

7.1       The
term of the Agreement shall be three (3) years from the Effective Date. Thereafter, the Agreement shall be renewed for successive one
(1) year terms, unless terminated upon three (3) months prior notice by either Party before the anniversary of the Agreement.

 

7.2       If
either Party is in breach of its obligations under this Agreement then the Party not in breach is entitled to serve notice in writing
to the Party in breach setting out details of the breach, what actions are required to correct the breach and allowing the Party in breach
thirty (30) days from the date of notification in writing to correct the breach.

 

7.3       Either
Party shall have the right to terminate this Agreement and/or an accepted Project Proposal, effective immediately upon written notice
to the other Party, should the other Party continue to be in material breach of this Agreement, provided, that a notice of material breach
pursuant to Section 7.2 has been served on the Party in material breach and the Party in material breach has failed to correct the material
breach within the thirty (30) day cure period.

 

7.4       Either
Party may terminate this Agreement, effective immediately upon written notice to the other Party, if the other Party: (i) files a voluntary
petition in bankruptcy or has an involuntary bankruptcy petition filed against it, which is not dismissed within thirty (30) days after
its institution, (ii) is adjudged as bankrupt, (iii) becomes insolvent, (iv) has a receiver, trustee, conservator or liquidator appointed
for all or a substantial part of its assets, (v) ceases to do business, (vi) commences any dissolution, liquidation or winding up, or
(vii) makes an assignment of its assets for the benefit of its creditors.

 

7.5       An
accepted Project Proposal or any other written assignment related to a Project Proposal may be terminated by Client at any time during
the term of this Agreement on sixty (60) days prior written notice to the Service Provider.

 

7.6       Except
in the event of a termination by Client according to Section 7.3, if this Agreement, any particular accepted Project Proposal or
any particular other written assignment related to a Project Proposal is terminated before any such Project Proposal or any such other
written assignment related to a Project Proposal is completed, Client shall pay Service Provider for all Services performed in accordance
with any such affected Project Proposal or any such other written assignment related to a Project Proposal hereunder, and reimburse the
Service Provider for all costs and expenses incurred in performing those Services.

 

7.7       The
termination of this Agreement shall not relieve either Party of its obligation to the other with respect to (a) maintaining the confidentiality
of information, (b) liability and, (c) compensation for Services performed through the date of termination.

 

8.0        MISCELLANEOUS

 

8.1       Assignment
and Subcontracting. This Agreement and any Project shall not be assigned by Bioarkive or its affiliated companies without the prior
written consent of Client, except in connection with the sale of the business to which this Agreement pertains.

 

Bioarkive shall have the
right to subcontract or delegate any portion of the Services hereunder to third parties (“Subcontractors”) only
with Client’s prior written consent; provided, that no consent shall be necessary for Bioarkive’s delegation to or use
of Subcontractors that are set forth in the relevant Project Proposal as performing such Services. In any event, Bioarkive shall
remain solely and fully liable for the performance of such Subcontractors to which it delegates the performance of its obligations
under this Agreement. Bioarkive shall ensure that each of its Subcontractors performs Bioarkive’s obligations pursuant to the
terms of this Agreement. For clarity, to the extent Bioarkive has an obligation under this Agreement to perform an action or to meet
a standard, and Bioarkive subcontracts such obligation, Bioarkive shall be responsible for any failure by its Subcontractor to
perform the action or meet the standard.

 

    
	BioArkive & Immuneering	7/11	 

     

    

 

8.2       Notice.
All notices required by this Agreement shall be in writing. All notices shall be sent by e-mail confirmed by registered or certified mail
to the Parties within three (3) business days at the following addresses or such other addresses as may be designated in writing by the
respective Parties:

 

	 	Notices to Bioarkive:	Bioarkive, LLC

 

11421 W Bernardo Court

Suite 200

San Diego, CA 92127

 

Attn. of: Praveen Nair, Ph.D. (CEO)

E-mail: pnair@bioarkive.com

 

	 	Notices to Company:	Immuneering

245
Main St, Second Floor

Cambridge,
MA 02142

 

Attn.
of: Peter King, Ph.D. (VP Discovery)

E-mail:
pking@immuneering.com

 

8.3       Force
Majeure. A Party shall be excused from performing its obligations under this Agreement if its performance is delayed or prevented
by any cause beyond such Party's control, including but not limited to, acts of God, fire, explosion, disease, weather, war, insurrection,
civil strife, riots, government action, or power failure. Performance shall be excused only to the extent of and during the reasonable
continuance of such disability. Any deadline or time for performance specified in an accepted Project Proposal that falls due during or
subsequent to the occurrence of any of the disabilities referred to herein shall be automatically extended for a period of time equal
to the period of such disability. Bioarkive shall immediately notify Client if, by reason of any of the disabilities referred to herein,
the Service Provider is unable to meet any deadline or time for performance specified in an accepted Project Proposal.

 

8.4       Independent
Contractor. Bioarkive shall perform each Project as an independent contractor and shall have complete and exclusive control over its
employees, consultants and agents. The Services rendered by Bioarkive are those of an independent contractor and not those of Client.
No Services rendered pursuant to this Agreement shall be construed to deem Bioarkive or its affiliated companies an employee, agent or
joint-venture with Client.

 

8.5       Waiver.
No waiver of any term, provision, or condition of this Agreement, whether by conduct or otherwise, in any one or more instances shall
be deemed to be or construed as a further or continuing waiver of any such term, provision, or condition or of any other term, provision,
or condition of this Agreement.

 

8.6       Severability.
This Agreement is divisible and separable so that if any provision(s) shall be held to be invalid, such invalidity shall not impair the
remaining provisions thereof.

 

8.7       Applicable
Law and Competent Court. This Agreement shall be governed by the laws of Delaware, USA. Any claim or controversy arising out of or
related to this Agreement or any breach hereof shall be submitted to the competent courts of the state of Delaware, USA, and each Party
hereby consents to the exclusive jurisdiction and venue of such court.

 

    
	BioArkive & Immuneering	8/11	 

     

    

 

8.8       Entire
Agreement. This Agreement, together with its attachments, represents the entire understanding of the Parties with respect to the subject
matter hereof and hereby supersedes all prior understanding and agreements, whether oral or written, between the Parties with respect
to any Services to be performed.

 

8.9       Attachments/Addenda.
Any attachment(s) and/or accepted Project Proposals are deemed to be an integrated part of this Agreement and all references to this Agreement
shall be deemed to include all such attachments and accepted Project Proposals.

 

8.10     Security.
Bioarkive warrants and represents that it shall maintain adequate security at its facilities for the term of this Agreement to ensure
that the Services and each Project are performed within the time frame set forth in an accepted Project Proposal, and such Services and
Project shall not be compromised or disrupted by any breach of security.

 

* * * *

 

    
	BioArkive & Immuneering	9/11	 

     

    

 

IN WITNESS WHEREOF, the Parties have caused this
Agreement to be executed, by duly authorized representatives on the Effective Date.

 

	Bioarkive	 	Immuneering Corporation
	 	 	 	 	 
	Date:	     August
    5, 2019	 	Date:	     August
    5, 2019
	 	 	 	 	 
	By:	     /s/
    Praveen Nair	 	By:	     /s/
    Benjamin J. Zeskind
	 	 	 	 	 
	Name:	     Praveen
    Nair	 	Name:	     Benjamin
    J. Zeskind
	 	 	 	 	 
	Title:	     CEO	 	Title:	     CEO

 

 

 

	Date:	 	 	Date:	 
	 	 	 	 	 
	By:	 	 	By:	 
	 	 	 	 	 
	Name:	 	 	Name:	 
	 	 	 	 	 
	Title:	 	 	Title:	 

 

    
	BioArkive & Immuneering	10/11	 

     

    

 

Appendix 1

 

Project
Proposal

 

The Project Proposal will contain amongst others the following elements
if relevant for the Project:

 

Background

 

Project description

 

Deliverables, requirements and general conditions

 

	 	·	Tasks
	 	·	Experimental details (methods)
	 	·	Starting and end date
	 	·	Resources
	 	·	Sub-contractors
	 	·	Pricing and costs
	 	·	Description
	 	·	Shipment details
	 	·	Contact persons
	 	·	Reporting
	 	·	Payment terms
	 	·	Validity

 

This Project Proposal is pursuant to, and incorporates the provisions
of the Master Services Agreement with Effective Date August 5th, 2019 by and between Bioarkive, LLC and Immuneering Corporation.

 

Bioarkive, LLC

 

	Dennis Garland, MS	Praveen Nair, Ph.D.
	Director of Operations	Chief Executive Officer

 

 CC:

 

Proposal accepted by Immuneering:

 

	Date:	 	 	Date:	 
	 	 	 	 	 
	By:	 	 	By:	 
	 	 	 	 	 
	Name:	 	 	Name:	 
	 	 	 	 	 
	Title:	 	 	Title:	 

 

    
	BioArkive & Immuneering	11/11Exhibit 10.3

 

September 17, 2019

 

PEF LLC

 

Subject: Advisor to Immuneering Corporation

 

Dear PEF LLC,

 

Immuneering Corporation (the “Company”) is
pleased to invite you to serve as an Advisor to the Company. This letter will set forth the terms and conditions of your participation
as an advisor to the Company commencing on the date hereof (the “Effective Date”).

 

1.          Services.
You agree to serve as an Advisor to the Company. You have been chosen for this position because of your expertise in areas that are consistent
with the Company's business and strategy, and your track record of successfully introducing us to new services clients, potential investors,
business partners, and academic key opinion leaders. As an Advisor, we hope that you will contribute to the success of the Company by
engaging in the following activities, as reasonably requested by the Company from time to time (the “Services”):

 

		Ø	Advising the Company through telephone, e-mail and in-person communications as well as attending periodic meetings (via telephone
or in-person) with other Advisors.

 

		Ø	Advising the Company on business matters in your area of expertise, including guidance on business strategy, partnership negotiations,
capital raising and similar matters.

 

		Ø	Introducing the Company to potential employees, consultants, investors, scientific collaborators, and business partners.

 

		Ø	Advising the Company on market strategies and trends in areas of interest to the Company.

 

		Ø	Endorsing the Company to potential business partners as well as to industry and financial analysts and “thought leaders.”

 

		Ø	Providing advice to the Company on matters related to the Company's research and development efforts, concepts and strategies.

 

Unless otherwise notified, I will serve as
your primary point of contact with the Company regarding your role as an Advisor. For avoidance of doubt, you shall not be required to
devote more than five hours per month to the performance of your duties hereunder.

 

2.          Compensation.
In consideration for your participation as an Advisor, you shall receive a warrant for the purchase of 73,000 shares of common stock of
the Company at a price per share equal to the fair market value at the time of Board approval. The warrant will vest immediately and be
exercisable on or after the one year anniversary of the Effective Date. The warrant will be exercisable immediately upon a change in control
of the Company.

 

     

     

    

 

You will be reimbursed for any reasonable travel
and incidental expenses incurred associated with serving as an Advisor, subject to the Company's generally applicable policies for the
reimbursement of employee expenses.

 

3.          Independent
Contractor. In performing Services for the Company pursuant to this letter agreement, you will
act in the capacity of an independent contractor with respect to the Company and not as an employee of the Company. You acknowledge that
you have no authority to act on behalf of the Company, including, without limitation, to enter into any contract or agreement on behalf
of and in the name of the Company. As an independent contractor, you will not be eligible to participate in any of the Company's employee
benefit plans, fringe benefit programs, group insurance arrangements or similar programs and you will be solely responsible for any tax
withholdings and the like.

 

4.          Conflict
of Interest. The Company recognizes and agrees that you may perform services for other persons
and entities, provided that such services do not represent a conflict of interest, such as by serving as an advisor for a direct competitor
of the Company, or a breach of your duties to the Company. By signing this letter agreement, you represent and warrant to the Company
that your participation as an Advisor to the Company will not be inconsistent with any other contractual commitments that you may already
have, and you agree that you will not disclose to the Company or induce the Company to use any confidential or proprietary information
or material belonging to any current or previous employer or others.

 

5.          Confidentiality.
You agree that all information, whether or not in writing, of a private, secret or confidential nature concerning the Company’s
business, business relationships, technology or financial affairs (collectively, “Confidential Information”)
is and shall be the exclusive property of the Company. During the term of this letter agreement and for a period of three years thereafter,
you will not, without the prior written consent of the Company, use for any purpose (except in the course providing Services under this
letter agreement in furtherance of the business of the Company) or disclose to any third party any Confidential Information. Confidential
Information will not include any information known generally to the public (other than as a result of unauthorized disclosure by you)
or information that you received from third parties who do not have an obligation to maintain the confidentiality of the information disclosed.
You may disclose the Company's Confidential Information if you are required to do so by law or court order, provided that you (i) promptly
notify the Company of such required disclosure and (ii) use all reasonable efforts to minimize the extent of such required disclosure.
You agree to deliver to the Company or destroy, as requested by the Company, at the termination of your service as an Advisor, or at any
other time that the Company may request, all written or electronic memoranda, notes, plans, records, reports and other documents (and
copies thereof) relating to the business of the Company which you may then possess or have under your control.

 

6.          Publicity.
The Company will not use your name, likeness or work product in connection with promotion of
its business, products and services or to allow others to do so without your prior written approval, provided that the Company may list
you on its website and in investor presentations as an advisor to the Company. You agree to use reasonable efforts to inform the Company
whether it may use your name, likeness or work product within five days after the Company notifies you of any such proposed use.

 

    	 	2	 

     

    

 

7.          Term
of Agreement. The term of your participation as an advisor shall be one (1) year from
the Effective Date, subject to renewal by our mutual agreement. You may terminate your participation as an advisor for any reason
with ten (10) days prior written notice. We may terminate your participation as an advisor for breach of the terms of this
letter Agreement that, if capable of being cured, is not cured within a reasonable time of no less than ten (10) days following
written notice of such breach by the Company to you. Following termination of this letter agreement, the provisions of paragraphs 5
through 8 shall survive.

 

8.          General
Provisions. This letter agreement (together your warrant agreement) contains all of the terms
of your participation as an Advisor of the Company and no agreements, representations or understandings (whether oral or written and whether
express or implied) which are not expressly set forth in this letter agreement have been made or entered into by either party with respect
to the subject matter hereof. You agree that any of the Company's rights or obligations hereunder may be assigned to any successor or
resultant corporation in a merger or consolidation or other acquisition of the Company or its subsidiary, but that you may not assign
any of your rights or obligations under this letter agreement without the prior written consent of the Company. This letter agreement
may not be amended or modified except by an express written agreement signed by you and a duly authorized officer of the Company. The
terms of this letter agreement and the resolution of any disputes will be governed by Massachusetts law without reference to its conflicts
of laws provisions. Any breach of paragraph 5 will cause irreparable harm to the Company for which damages would not be an adequate remedy,
and therefore the Company will be entitled to seek injunctive relief with respect thereto in addition to any other remedies.

 

[Signature page follows.]

 

    	 	3	 

     

    

 

We hope that you find the foregoing terms acceptable.
You may indicate your agreement with these terms and accept this offer by signing and dating the enclosed duplicate original of this letter
and returning it to me. This offer, if not accepted, will expire at the close of business on September 20, 2019.

 

	 	Very truly yours,
	 	 	 
	 	Immuneering Corporation
	 	 	 
	 	 	 
	 	By:	/s/ Benjamin J. Zeskind
	 	Name:	Benjamin J. Zeskind
	 	Title:	Co-Founder and CEO

 

[Signature Page to
Advisory Agreement]

 

     

     

    

 

I have read, understand and accept this offer:

 

 

	PEF LLC	 
	 	 	 
	 	 	 
	By:	/s/ Peter Feinberg	 
	Name: 	Peter Feinberg 	 
	Title: 	Manager Member	 
	 	 	 
	Dated:	 	 

 

[Signature Page to
Advisory Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]